Abstract Coronavirus disease 2019 (COVID‐19) is still propagating a year after the start of
the pandemic. Besides the complications patients face during the COVID‐19 disease period …

Though the exact etiology of autoimmune diseases still remains unknown, there are various
factors which are believed to contribute to the emergence of an autoimmune disease in a …

Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in
overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the …

Acute COVID-19, caused by SARS-CoV-2, is characterized by diverse clinical presentations,
ranging from asymptomatic infection to fatal respiratory failure, and often associated with …

Coronavirus disease 2019 (COVID-19), has affected millions of people globally, since it was
declared a global emergency in March 2019 by World Health Organization. Its clinical …

This article provides an overview of various aspects related to post-COVID syndrome. Apart
from its prevalence, symptoms and sequelae, risk determinants, and psychosocial …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

With the progression of the COVID-19 pandemic, there have been different reports about the
development of autoimmune diseases once the infection is controlled. After entering the …

SARS-Cov-2 virus has attracted a lot of attention globally, due to the autoimmune and
inflammatory processes that were observed during the development of Covid-19 disease …

Accumulating evidence shows that SARS‐CoV‐2 can potentially trigger autoimmune
processes, which can be responsible for the long‐term consequences of COVID‐19 …